Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tesla Motors Inc (TSLA) News: Raised Price Target, Inconvenient Truth & A Scared Nissan Motor Co., Ltd. (ADR) (NSANY)

Editor’s Note: Related tickers: Tesla Motors Inc (NASDAQ:TSLA), Nissan Motor Co., Ltd. (ADR) (OTCMKTS:NSANY)

Tesla Motors (TSLA): Buy, Sell or Hold? (WallStreetPit)
Tesla Motors Inc (NASDAQ:TSLA) price target raised to $118 from $70 at Robert W. Baird drew heated sentiment from the CNBC’s “Fast Money” traders Wednesday. OptionMonster’s Jon Najarian was against a potential upside of 21% from the company’s current price. “I don’t know why you wouldn’t love this stock,” he said. “Look, in May the sales were down, the car sales were down about 15 percent. What’s wrong with that? Or a 95 forward P/E [Tesla’s stock trades at more than 550x projections for earnings this fiscal year]. Or the fact this they lose about 30 percent on every car. What’s not to like?”

Tesla Motors Inc (NASDAQ:TSLA)

Is Nissan Afraid to Compete With Tesla? (Fool)
Is Nissan Motor Co., Ltd. (ADR) (OTCMKTS:NSANY) afraid to compete with Silicon Valley upstart Tesla Motors Inc (NASDAQ:TSLA)? Nissan Motor Co., Ltd. (ADR) (OTCMKTS:NSANY)’s plans to launch an all-electric luxury car next year looked likely to make the Japanese auto giant — which has had big success with its all-electric Leaf compact — the first big automaker to go head-to-head with Tesla. But now, those plans appear to be off. What’s going on?

Tesla shares rise on optimism about new models (BusinessWeek)
Shares of Tesla Motors Inc (NASDAQ:TSLA) rose Wednesday on optimism about that the electric car maker will be able to meet production targets for its new models. THE SPARK: Baird analyst Ben Kallo boosted his price target for Tesla stock by $48 to $118, saying that the recent success of the company’s Model S sedan, coupled with its cash position, allows investors to look ahead to its planned “X” and “Gen III” vehicles.

Tesla Isn’t Standing on Its Own Yet (WSJ)
Todd Foley of the American Council On Renewable Energy (Letters, June 5) ignores the gist of the Journal’s editorial critique of Tesla Motors Inc (NASDAQ:TSLA) +3.34% (“The Other Government Motors,” May 24) and encourages us all to celebrate Tesla’s early repayment of its DOE loan. Mr. Foley fails to refute the inconvenient truth that Tesla’s revenues and profits involved a healthy dose of income redistribution from federal and state taxpayers and from rival car makers and their customers. So those of us who pay taxes and buy non-Tesla vehicles provided a loan to Tesla and then, in effect, gave Tesla the money to repay us—with interest.

Tesla Motors PT Raised to $118.00 at Robert W. Baird (TSLA) (UtahPeopleSpost)
Investment analysts at Robert W. Baird lifted their price objective on shares of Tesla Motors Inc (NASDAQ:TSLA) from $70.00 to $118.00 in a note issued to investors on Wednesday, AnalystRatings.Net reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective indicates a potential upside of 20.74% from the company’s current price. A number of other firms have also recently commented on TSLA. Analysts at TheStreet reiterated a “buy” rating on shares of Tesla Motors Inc (NASDAQ:TSLA) in a research note to investors on Wednesday, June 5th. Separately, analysts at Bank of America reiterated an “underperform” rating on shares of Tesla Motors Inc (NASDAQ:TSLA) in a research note to investors on Monday, May 20th.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!